Drug intelligence / Profile preview

alpha-tocopheryl acetate

Development stage
Unknown
Lead developer
Vanderbilt University
Modality
Small Molecules
Administration
Oral
01

Overview

Natural source d-α-tocopheryl acetate is a specific, naturally derived form of Vitamin E (RRR-alpha-tocopheryl acetate) that functions as a potent antioxidant and immune modulator. Developed and studied by Vanderbilt University, it has been investigated for the treatment of mild allergic (atopic) asthma. The compound acts by scavenging reactive oxygen species (ROS), thereby reducing oxidative stress markers like F2-isoprostanes in the airway. Furthermore, it modulates the inflammatory milieu by inhibiting Th2 cytokines such as IL-4 and IL-5 while promoting the production of the Th1-associated cytokine IL-12. Clinical evidence suggests that high-dose oral supplementation (1,500 IU) can reduce allergen-induced airway inflammation and improve airway hyperresponsiveness to methacholine.

Brand names
E-Gems
Other names
natural source d-alpha-tocopheryl acetateRRR-alpha-tocopheryl acetateVitamin Ed-alpha-tocopheryl acetate
02

Targets

ALOX5 (Arachidonate 5-lipoxygenase)IL4R (Interleukin-4 receptor alpha subunit)PKC (Protein kinase C family)

Beyond the preview

Go deeper on alpha-tocopheryl acetate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on alpha-tocopheryl acetate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call